|
VPS41 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.402200E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.097600E-02 |
| Normal-vs-Stage2 |
2.221600E-01 |
| Normal-vs-Stage3 |
1.745520E-02 |
| Normal-vs-Stage4 |
9.537700E-02 |
| Stage1-vs-Stage2 |
7.153000E-01 |
| Stage1-vs-Stage3 |
4.454800E-01 |
| Stage1-vs-Stage4 |
9.558000E-01 |
| Stage2-vs-Stage3 |
3.988000E-01 |
| Stage2-vs-Stage4 |
7.940000E-01 |
| Stage3-vs-Stage4 |
5.446200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.639900E-02 |
| Normal-vs-AfricanAmerican |
9.156800E-01 |
| Normal-vs-Asian |
1.367800E-02 |
| Caucasian-vs-AfricanAmerican |
1.955780E-01 |
| Caucasian-vs-Asian |
3.285400E-01 |
| AfricanAmerican-vs-Asian |
6.112000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.041500E-03 |
| Normal-vs-Female |
9.664100E-02 |
| Male-vs-Female |
3.756300E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.778350E-01 |
| Normal-vs-Age(41-60Yrs) |
8.304100E-03 |
| Normal-vs-Age(61-80Yrs) |
1.042770E-01 |
| Normal-vs-Age(81-100Yrs) |
1.328610E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.110450E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.006800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.732400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.239400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.019200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.531600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.052000E-01 |
| Classical-VS-Follicular |
2.773800E-02 |
| Classical-VS-Other |
8.582400E-02 |
| Classical-VS-Normal |
1.727020E-01 |
| Tall-VS-Follicular |
4.148400E-01 |
| Tall-VS-Other |
1.200640E-01 |
| Tall-VS-Normal |
1.409630E-01 |
| Follicular-VS-Other |
3.865000E-01 |
| Follicular-VS-Normal |
9.757600E-03 |
| Other-VS-Normal |
2.097600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.253900E-02 |
| Normal-vs-N1 |
1.953530E-02 |
| N0-vs-N1 |
6.979600E-01 |
|
|
